Schizoaffective disorder-an ongoing challenge for psychiatric nosology

European Psychiatry

Volumn 26, Issue 3, 2011, Pages 159-165

  Jager M ^a   Haack, S ^a,b   Becker, T ^a   Frasch, K ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Classification; Diagnosis; Nosology; Psychosis

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; VALPROIC ACID;

AFFECTIVE PSYCHOSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DRUG EFFICACY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SHORT SURVEY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

DIAGNOSIS, DIFFERENTIAL; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA;

EID: 79953303623     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2010.03.010     Document Type: Short Survey

References (110)

1. Allardyce J., Gaebel W., Zielaseck J., Van Os J. Deconstructing psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosis. Schizophr Bull 2007, 33:863-867.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision (DSM-IV-TR). Washington DC: American Psychiatric Association; 2000.
3. Andreasen N.C. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand 2006, 113:81.
4. Angst J., Felder W., Lohnmeyer B. Schizoaffective disorders. Results of a genetic investigation, I. J Affect Disord 1979, 1:139-153.
5. Angst J., Scharfetter C., Stassen H.H. Classification of schizo-affective patients by multidimensional scaling and cluster analysis. Psychiatr Clin 1993, 16:254-264.
6. Baethge C. Long-term treatment of schizoaffective disorder. Review and recommendations. Pharmacopsychiatry 2003, 36:45-56.
7. Baethge C., Gruschka P., Berghöfer A., Baur M., Müller-Oerlinghausen B., Bschor T., et al. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up. J Affect Disord 2004, 79:43-50.
8. Basan A., Leucht S. Valproate for schizophrenia. Cochrane Database Syst Rev 2004, CD004028.
9. Benabarre A., Vieta E., Colom F., Nartinez-Aran A., Reinares M., Casto C. Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences. Eur Psychiatry 2000, 16:167-172.
10. Brockington I.F., Kendell R.E., Winwright S., Hiller V.F., Walker J. The distinction between affective psychoses and schizophrenia. Br J Psychiatry 1979, 135:243-248.
11. Brockington I.F., Kendell R.E., Wainwright S. Depressed patients with schizophrenic or paranoid symptoms. Psychol Med 1980, 10:665-675.
12. Brockington I.F., Wainwright D., Kendell R.E. Manic patients with schizophrenic or paranoid symptoms. Psychol Med 1980, 10:73-83.
13. Cheniaux E., Landeira-Fernandez J., Telles L.L., Lessa J.L.M., Duncan T., Versiani M. Does schizoaffective disorder really exists? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorder?. J Affect Disord 2008, 106:209-217.
14. Ciapparelli A., Dell'Osso L., Pini S., Chiavacci M.C., Fenzi M., Cassano G. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study. J Clin Psychiatry 2000, 61:329-334.
15. Clark L. State and trait-related deficits in sustained attention in bipolar disorder: are there any overlaps with schizophrenia. The overlap of affective and schizophrenic spectra 2007, 79-103. Cambridge University Press, Cambridge. A. Marneros, H.S. Akiskal (Eds.).
16. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960, 20:37-46.
17. Coryell W., Zimmerman M. The heritability of schizophrenia and schizoaffective disorder. A family study. Arch Gen Psychiatry 1988, 45:323-327.
18. Coryell W. Phenomenological approaches to the schizoaffective spectrum. The overlap of affective and schizophrenic spectra 2007, 133-144. Cambridge University Press, Cambridge. A. Marneros, H.S. Akiskal (Eds.).
19. Craddock N., Owen M.J. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 2005, 186:364-366.
20. Craddock N., O'Donovan M.C., Owen M.J. Genes for schizophrenia and bipolar disorder. Implications for psychiatric nosology. Schizophr Bull 2006, 32:9-16.
21. Del Rio Vega J.M., Ayuso-Guierrez J.L. Course of schizoaffective psychosis. A retrospective study. Acta Psychiatr Scand 1990, 81:534-537.
22. Essen-Möller E. On classification of mental disorders. Acta Psychiatr Scand 1962, 37:119-126.
23. Frangou S., Dakhil N., Landau S., Kumari V. Fronto-temporal function may distinguish bipolar disorder from schizophrenia. Bipolar Disord 2006, 8:47-55.
24. Gaebel W., Zielaseck J. The DSM-V initiative " deconstructing psychosis" in the context of Kraepelin's concept on nosology. Eur Arch Psychiatry Clin Neurosci 2008, 258(suppl. 2):41-47.
25. Gardno A.G., Rijsdijk F.V., Sham P.C., Murray R.M., McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 2002, 159:539-545.
26. Green E., Raybould R., Macgregor S., Gordon-Smith K., Heron J., Hyde S., et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry 2005, 62:642-648.
27. Greil W., Ludwig-Mayerhofer W., Erazo N., Schöchlin C., Schmidt S., Engel R.R., et al. Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomized study. Eur Arch Psychiatry Clin Neurosci 1997, 247:42-50.
28. Grossman L.S., Harrow W., Goldberg J.F., Fichter C.G. Outcome of schizoaffective disorder at two long-term follow-ups: comparison with outcome of schizophrenia and affective disorders. Am J Psychiatry 1991, 148:1359-1365.
29. Gruber O., Gruber E., Falkai P. Articulatory rehearsal in verbal working memory: a possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder. Neurosci Lett 2006, 405:24-28.
30. Haahr U., Friis S., Larsen T.K., Melle I., Johannessen J.O., Opjordsmoen S., et al. First-episode psychosis: diagnostic stability over one and two years. Psychopathology 2008, 41:322-329.
31. Hamshere M.L., Bennett P., Williams N., Segurado R., Cardno R., Norton N., et al. Genomewide linkage scan in schizoaffective disorder. Significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry 2005, 62:1081-1088.
32. Harrow M., Grossman L.S., Herbener E.S., Davies W.E. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry 2000, 177:421-426.
33. Heckers S. Is schizoaffective disorder a useful diagnosis?. Curr Psychiatry Rep 2009, 11:332-337.
34. Hiller W., Dichtl G., Hecht H., Hundt W., Von Zerssen D. An empirical comparison of diagnosis and reliabilities in ICD-10 and DSM-III-R. Eur Arch Psychiatry Clin Neurosci 1993, 242:209-217.
35. Himmelhoch J.M., Fuchs C.Z., May S.J., Symons J., Neil J.F. When a schizoaffective diagnosis has meaning. J Nerv Ment Dis 1981, 169:277-282.
36. Hodgkinson C.A., Goldman D., Jaeger J., Persaud S., Kane J.M., Lipsky R.H., et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 2004, 75:862-872.
37. Jablensky A., Woodbury M.A. Dementia praecox and manic-depressive insanity in 1908: a grade of membership analysis of the Kraepelinian dichotomy. Eur Arch Psychiatry Clin Neurosci 1995, 245:202-209.
38. Jablensky A. Classification of nonschizophrenic psychotic disorders: a historical perspective. Curr Psychiatry Rep 2001, 3:326-331.
39. Jäger M., Bottlender R., Strauss A., Möller H.J. On the descriptive validity of ICD-10 schizophrenia: empirical analyses in the spectrum of non-affective functional psychoses. Psychopathology 2003, 36:152-159.
40. Jäger M., Bottlender R., Strauss A., Möller H.J. Classification of functional psychoses and its implication for prognosis. Comparison between ICD-10 and DSM-IV. Psychopathology 2004, 37:110-117.
41. Jäger M., Bottlender R., Strauss A., Möller H.J. 15 year follow-up of ICD-10 schizoaffective disorders compared with schizophrenia and affective disorders. Acta Psychiatr Scand 2004, 109:30-37.
42. Jäger M., Frasch K., Becker T. New ways in psychiatric diagnostics?. Fortschr Neurol Psychiatr 2008, 76:186-293.
43. Jäger M., Becker T., Weinmann S., Frasch K. Treatment of schizoaffective disorder - a challenge for evidence-based psychiatry. Acta Psychiatr Scand 2010, 121:22-32.
44. Janicak P.G., Keck P.E., Davis J.M., Kasckow J.W., Tugrul K., Dowd D.M., et al. A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder. J Clin Psychopharmacol 2001, 21:360-368.
45. Jaspers K. Allgemeine Psychopathologie. 3rd ed 1923, Springer, Heidelberg.
46. Kasanin J. The acute schizoaffective psychoses. Am J Psychiatry 1933, 13:97-126.
47. Keck P.E., Reeves K.R., Harrigan E.P. Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double-blind, placebo-controlled, multicenter studies. J Clin Psychopharmacol 2001, 21:27-35. the Ziprasidone Study Group.
48. Kelsoe J.R. The overlapping of the spectra: overlapping genes and genetic models. The overlap of affective and schizophrenic spectra 2007, 25-42. Cambridge University Press, Cambridge. A. Marneros, H.S. Akiskal (Eds.).
49. Kempf L., Hussain N., Potash J.B. Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the border. Int Rev Psychiatr 2005, 17:9-19.
50. Kendell R.E. The role of diagnosis in psychiatry 1975, Blackwell Scientific Publications, Oxford.
51. Kendell R.E., Gourlay J. The clinical distinction between the affective psychoses and schizophrenia. Br J Psychiatry 1970, 117:261-266.
52. Koh P.O., Undie A.S., Kabbani N., Levenson R., Goldman-Rakic P.S., Lidow M.S. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci U S A 2003, 100:313-317.
53. e ed 1899, Barth, Leipzig.
54. Lake C.R., Hurwitz N. Schizoaffective disorders are psychotic mood disorders; there are no schizoaffective disorders. Psychiatry Res 2006, 143:255-287.
55. Lake C.R., Hurwitz N. Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease - there is no schizoaffective disorder. Curr Opin Psychiatry 2007, 20:365-379.
56. Lake CR, Hurwitz N. Schizoaffective disorder - its raise and fall: perspectives for DSM-V. Clin Schizophr Relat Psychoses 2008; DOI: 10.3371/CSRP.2.1.8.
57. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
58. Lange W., Munk-Jorgenson P., Bertelsen A., Schürmann A., Michels R., Malchow C.P., et al. Comparison of psychiatric ICD-10 diagnoses in Denmark and Germany. Psychopathology 2002, 35:26-47.
59. Langfeld G. The Schizophreniform States 1939, Munskgaard, Copenhagen.
60. Laursen T.M., Labouriau R., Licht R.W., Bertelsen A., Munk-Olsen T., Mortensen P.B. Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study. Arch Gen Psychiatry 2005, 62:841-848.
61. Lasser R., Bossie C.A., Gharabawi G., Eerdekens M., Nasrallah H.A. Efficacy and safety of long-acting risperidon in stable patients with schizoaffective disorders. J Affect Disord 2004, 83:263-275.
62. Lencz T., Lipsky R.H., DeRosse P., Burdick K.E., Kane J.M., Malhotra A.K. Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes. Br J Psychiatry 2009, 194:313-318.
63. Leucht S., McGrath J., Kissling W. Lithium for schizophrenia. Cochrane Database Syst Rev 2007, CD003834.
64. Leucht S., McGrath J., Kissling W., White P. Carbamazepin for schizophrenia. Cochrane Database Syst Rev 2007, CD001258.
65. Leonhard K. Die Aufteilung der endogenen Psychosen und ihre differenzierte Ätiologie 1957, Akademie, Berlin.
66. Levinson D.F., Umapathy C., Musthaq M. Treatment of schizoaffective disorder and schizophrenia with mood symptoms. Am J Psychiatry 1999, 156:1138-1148.
67. Lindenmayer J.P., Kay S.R., van Praag H. Distinction of schizoaffective from schizophrenic profile. Schizophr Res 1989, 2:423-424.
68. Maier W. Do schizoaffective disorders exist at all?. Acta Psychiatr Scand 2006, 13:369-371.
69. Maier W., Lichtermann D., Franke P., Heun R., Falkai P., Rietschel M. The dichotomy of schizophrenia and affective disorders in extended pedigrees. Schizophr Res 2002, 57:259-266.
70. Maj M. Clinical course and outcome of schizoaffective disorders. A three-year follow-up study. Acta Psychiatr Scand 1985, 72:542-550.
71. Maj M. Lithium prophylaxis of schizoaffective disorders: a prospective study. J Affect Disord 1988, 14:129-135.
72. Maj M., Pirozzi R., Formicola A.M., Bartolli L, BucciI P. Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. J Affect Disord 2000, 57:95-98.
73. Malhi G.S., Green M., Fagiolini E.D., Peselow E., Kumari V. Schizoaffective disorder: diagnostic issues and further recommendations. Bipolar Disord 2008, 10:215-230.
74. Marneros A., Deister A., Rhode A. Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course. Acta Psychiatr Scand 1990, 82:352-358.
75. Marneros A. Do schizoaffective disorders exist at all?. Acta Psychiatr Scand 2007, 115:162.
76. Marneros A. Schizophrenie-ähnliche Störungen und nichtorganische Wahnerkrankungen. Psychiatrie und Psychotherapie. 3rd ed 2008, 357-390. Springer, Berlin. H.J. Möller, G. Laux, H.P. Kapfhammer (Eds.).
77. Marneros A., Röttig S., Röttig D., Tscharntke A., Brieger P. Bipolar I disorder with mood-incongruent psychotic symptoms: a comparative longitudinal study. Eur Arch Psychiatry Clin Neurosci 2009, 259:121-136.
78. Mattes J.A., Nayak D. Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizo-affectives. Biol Psychiatry 1984, 19:445-449.
79. McCullumsmith, Meador-Woodruff J.H. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 2002, 26:368-375.
80. McElroy S.L., Keck P.E., Strakowski S.M. An overview of the treatment of schizoaffective disorder. J Clin Psychiatry 1999, 60(suppl. 5):16-21.
81. McGlashan T.H., Williams P.V. Schizoaffective psychosis. I. Comparative long-term outcome. Arch Gen Psychiatry 1987, 44:130-137.
82. Menuk M., Legault S., Schmidt P., Remington G. The nosological status of the remitting atypical psychoses. Compr Psychiatry 1989, 30:53-73.
83. Möller H.J., Hohe-Schramm M., Cording-Tömmel C., Schmid-Bode W., Wittchen H.U., Zaudig M., et al. The classification of functional psychoses and its implications for prognosis. Br J Psychiatry 1989, 154:467-472.
84. Möller H.J. Systematic of psychiatric disorders between categorical and dimensional approaches. Eur Arch Psychiatry Clin Neurosci 2008, 258(suppl. 2):48-73.
85. Okasha A. The concept of schizoaffective disorder: utility versus validity and reliability - a transcultural perspective. The overlap of affective and schizophrenic spectra 2007, 104-132. Cambridge University Press, Cambridge. A. Marneros, H.S. Akiskal (Eds.).
86. Olfson M., Marcus S.C., Wan G.J. Treatment patterns for schizoaffective disorder and schizophrenia among Medicaid patients. Psychiatr Serv 2009, 60:210-216.
87. Peralta V., Cuesta M.J. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach. J Affect Disord 2008, 108:71-86.
88. Pillmann F., Marneros A. The overlapping spectra: brief and acute psychoses. The overlap of affective and schizophrenic spectra 2007, 182-206. Cambridge University Press, Cambridge. A. Marneros, H.S. Akiskal (Eds.).
89. Pini S., de Queiroz V., Dell'Osso L., Abelli M., Mastrocinque C., Saettoni M., et al. Cross-sectional similarities and differences between schizophrenia, schizoaffective disorder and mania or mixed mania with mood-incongruent psychotic features. Eur Psychiatry 2004, 19:8-14.
90. Pope H.G., Lipinski J.F., Cohen B.M., Axelrod D.T. Schizoaffective disorder": an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia and affective disorder. Am J Psychiatry 1980, 137:921-927.
91. Reite M., Teale P., Rojas D.C., Sheeder J., Arciniegas D. Schizoaffective disorder: evidence for reversed cerebral asymmetry. Biol Psychiatry 1999, 46:133-136.
92. Roy P.D., Zipursky R.B., Saint-Cyr J.A., Bury A., Langevin R., Seeman M.V. Temporal horn enlargement is present in schizophrenia and bipolar disorder. Biol Psychiatry 1998, 44:418-422.
93. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines team for the treatment of schizophrenia and related disorders. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005;39:1-30.
94. Sartorius N., Kaelber C.T., Cooper J.E., Roper M.T., Rae D.S., Gulninat W., et al. Progress toward achieving a common language in psychiatry. Results from the field trial of the clinical guidelines accompanying the WHO classification of mental and behavioural disorders in ICD-10. Arch Gen Psychiatry 1993, 50:115-124.
95. Sartorius N., Üstüm T.B., Korten A., Cooper J.E., van Drimmelem J. Progress toward achieving a common language in psychiatry. II. Results from the international field trials of ICD-10 diagnostic criteria for research for mental and behavioural disorders. Am J Psychiatry 1995, 152:1427-1431.
96. Schimmelmann B.G., Conus P., Edwards J., McGorry P.D., Lambert M. Diagnostic stability 18 months after treatment initiation for first-episode psychosis. J Clin Psychiatry 2005, 66:1239-1246.
97. Schürhoff F., Szöke A., Méary A., Bellivier F., Rouillon F., Pauls D., et al. Familiar aggregation of delusional proneness in schizophrenia and bipolar pedigrees. Am J Psychiatry 2003, 160:1313-1319.
98. Schwartz J.E., Fennig S., Tanenberg-Karant M., Carlosn G., Craig T., Galambos N., et al. Congruence of diagnoses 2 years after first-admission diagnosis of psychosis. Arch Gen Psychiatry 2000, 57:593-600.
99. Stassen H.H., Scharfetter C., Angst J. Functional psychoses: molecular-genetic evidence for a continuum. The overlap of affective and schizophrenic spectra 2007, 55-78. Cambridge University Press, Cambridge. A. Marneros, H.S. Akiskal (Eds.).
100. Strömgren E. The development of the concept of reactive psychoses. Psychopathology 1987, 20:62-67.
101. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
102. Tsuang M.T., Dempsey G.M. Long-term outcome of major psychoses. II. Schizoaffective disorder compared with schizophrenia, affective disorders, and a surgical control group. Arch Gen Psychiatry 1979, 36:1302-1304.
103. Tsuang D., Coryell W An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder and schizophrenia. Am J Psychiatry 1993, 150:1182-1188.
104. Vallés V., Van Os J., Guillamat R., Gutiérrez B., Campillo M., Gento Fañanás L. Increased morbid risk for schizophrenia in families of inpatients with bipolar disorders. Schizophr Res 2000, 42:83-90.
105. Vieta E., Goikolea J.M., Corbella B., Benabarre A., Reinares M., Martínez G., et al. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-months, multicenter, open study. J Clin Psychiatry 2001, 62:818-825.
106. Vollmer-Larsen A., Jacobsen T.B., Hemmingsen R., Parnas J. Schizoaffective disorder - the reliability of its clinical diagnostic use. Acta Psychiatr Scand 2006, 113:402-407.
107. Welner A., Croughan J.L., Fishman R., Robins E. The group of schizoaffective and related psychoses - critique, record, follow-up and family studies: a follow-up study. Compr Psychiatry 1977, 18:413-422.
108. WHO. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva: WHO; 1993.
109. Wimmer A. Psykogene Sindssygdomsformer. In: Wimmer A, editor. St. Hans Hospital 1816-1915. Jubilaeumsskrift, Kobenhavn GEC: Grad Publishers; 1916.
110. Zaudig M., Stieglitz R.D., Gastpar M., Rosinger C. Mood (affective) and schizoaffective disorders (section F3): results of the ICD-10 field trial. Pharmacopsychiatry 1990, 23(suppl. 4):160-164.